Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine can reduce the risk of complications following ...
WARREN, N.J., April 9, 2008 – According to a study published in The New England Journal of Medicine this week, three-year data from the Stenting and Angioplasty with Protection in Patients at High ...
(PHILADELPHIA) – Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at ...
Elective carotid artery angioplasty and stenting was initiated in the United States in 1994 by the endovascular interventional team at the University of Alabama at Birmingham. Carotid stenting was ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
As with the CardioShield Application Protects During Transluminal Intervention of Vein Grafts by Reducing Emboli (CAPTIVE) study, the Protection During Saphenous Vein Graft Intervention to Prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback